Literature DB >> 18333149

Gastroduodenal ulceration following hepatic arterial chemotherapy: the role of methylene blue endoscopy in the investigation of pain.

M L Talbot1, J R Clark, P C Clingan, D L Morris.   

Abstract

BACKGROUND: Unintended perfusion of the gastroduodenum may complicate hepatic arterial chemotherapy leading to mucosal ulceration. PATIENTS AND METHODS: In a review of 233 consecutive hepatic artery catheters placed, 61 patients were investigated for chemotherapy-related epigastric pain. Investigations included catheter imaging, upper gastrointestinal endoscopy with methylene blue injection via the hepatic artery catheter and angiography.
RESULTS: Twenty patients (33%) demonstrated blue staining of the gastroduodenum. Angiography performed in 15 of these patients confirmed a misperfusing vessel in 13.The aberrant artery was successfully embolised and infusional chemotherapy recommenced in 11 patients. Forty-one patients had a negative dye test, of whom three had gastroduodenal ulcers, 14 had oesophagitis or gastroduodenitis, ten had catheter complications (leak n=2, arteritis n=5, pseudoaneurysm n=1, sepsis n=1), three had liver collections, five had floxuridine cholangitis and one had myocardial ischaemia. No cause could be found in 8 patients. No patient with a negative dye test developed unintended perfusion on repeat investigation.

Entities:  

Year:  2002        PMID: 18333149      PMCID: PMC2023909          DOI: 10.1080/136518202753598708

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  23 in total

1.  Late results justify resection for multiple hepatic metastases from colorectal cancer.

Authors:  M Rees; G Plant; S Bygrave
Journal:  Br J Surg       Date:  1997-08       Impact factor: 6.939

2.  Hepatic intra-arterial methylene blue injection during endoscopy: a method of detecting gastroduodenal misperfusion in patients receiving hepatic intra-arterial chemotherapy via an implanted pump.

Authors:  J W Frye; A P Venook; J W Ostroff; S J Mulvihill; R S Warren; C A Pellegrini; E J Ring; R J Stagg
Journal:  Gastrointest Endosc       Date:  1992 Jan-Feb       Impact factor: 9.427

3.  A study of prognostic factors for hepatic resection for colorectal metastases.

Authors:  M Taylor; J Forster; B Langer; B R Taylor; P D Greig; C Mahut
Journal:  Am J Surg       Date:  1997-06       Impact factor: 2.565

4.  Endoscopic demonstration of malperfusion by hepatic artery catheter.

Authors:  D S Perera; D L Morris
Journal:  Endoscopy       Date:  1998-05       Impact factor: 10.093

5.  The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth.

Authors:  N B Ackerman
Journal:  Surgery       Date:  1974-04       Impact factor: 3.982

6.  Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices.

Authors:  S A Curley; J L Chase; M S Roh; D C Hohn
Journal:  Surgery       Date:  1993-11       Impact factor: 3.982

Review 7.  Resection of hepatic metastases from colorectal cancer. Biologic perspective.

Authors:  G Steele; T S Ravikumar
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

8.  Gastric mucosal injury after hepatic arterial infusion chemotherapy with floxuridine. A clinical and pathologic study.

Authors:  M I Doria; L K Doria; J Faintuch; B Levin
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

9.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

Authors:  N Kemeny; J Daly; B Reichman; N Geller; J Botet; P Oderman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

10.  Factors influencing the natural history of colorectal liver metastases.

Authors:  R Stangl; A Altendorf-Hofmann; R M Charnley; J Scheele
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.